FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1758-1759 December 2, 1999 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Towner, D. PubMed Citation

In May 1998, the Food and Drug Administration (FDA) issued a public health advisory to all practitioners who deliver babies. The advisory, entitled "Need for Caution When Using Vacuum Assisted Delivery Devices,"¹ was based on reports to the FDA of 12 deaths and 9 serious injuries during vacuum deliveries in the preceding four years. In the 12 years before that period, much smaller numbers of such complications had been reported. The advisory noted the most serious complications of vacuum delivery — subgaleal hematoma and intracranial hemorrhage — and emphasized that vacuum devices should be used only for specific obstetrical indications.

. . . [Full Text of this Article]

References

This article has been cited by other articles:

• Littleford, J. (2004). Effects on the fetus and newborn of maternal analgesia and anesthesia: a review: [Les effets de l'analgesie et de l'anesthesie de la mere sur le foetus et le nouveau-ne: une revue]. Canadian J. Anesthesia 51: 586-609 [Abstract] [Full Text]